Kjems Lise Lund 4
4 · Cyclo Therapeutics, Inc. · Filed Mar 2, 2022
Insider Transaction Report
Form 4
Kjems Lise Lund
Chief Medical Officer
Transactions
- Award
Stock Option (Right to buy)
2022-02-28+31,141→ 31,141 totalExercise: $3.26Exp: 2032-02-28→ Common Stock (31,141 underlying)
Footnotes (1)
- [F1]The option vests over a four year period in equal monthly installments.